Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Healing & Recovery
Gastric pentadecapeptide with broad tissue-healing properties.
Peptide B
Peptide Blends
The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair.
Typical vial
5 mg
Typical dose
250-500 mcg
Half-life
~4 hours (estimated from animal pharmacokinetic data)
FDA status
Not FDA approved for human use. FDA issued a warning letter …
Typical vial
20 mg
Typical dose
250 + 2000 (BPC + TB) mcg
Half-life
BPC-157 ~4 h; TB-500 ~6-8 h
FDA status
Neither component is FDA approved for human use. FDA issued …
BPC-157 effects
Wolverine Blend (BPC-157 + TB-500) effects
BPC-157 side effects
Wolverine Blend (BPC-157 + TB-500) side effects
BPC-157 dosing ranges
General tissue repair
250-500 mcg · Once or twice daily · 4-6 weeks
Gut healing
250-500 mcg · Twice daily (oral or SubQ) · 4-8 weeks
Acute injury recovery
500 mcg · Twice daily near injury site · 2-4 weeks
Wolverine Blend (BPC-157 + TB-500) dosing ranges
Acute soft-tissue injury (loading)
250-500 mcg BPC + 2-5 mg TB-500 · BPC daily, TB-500 twice weekly · 4-6 weeks
Chronic tendinopathy
250 mcg BPC + 2 mg TB-500 · BPC daily, TB-500 weekly · 6-8 weeks
Maintenance after recovery
250 mcg BPC + 2 mg TB-500 · BPC 3-4x weekly, TB-500 fortnightly · 4 weeks
BPC-157: Gastric pentadecapeptide with broad tissue-healing properties. Typical dose 250-500 mcg. Wolverine Blend (BPC-157 + TB-500): The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair. Typical dose 250 + 2000 (BPC + TB) mcg. Both fall under the Healing & Recovery and Peptide Blends categories.
Stacking BPC-157 with Wolverine Blend (BPC-157 + TB-500) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
BPC-157 is typically dosed: Once or twice daily for General tissue repair; Twice daily (oral or SubQ) for Gut healing; Twice daily near injury site for Acute injury recovery. Wolverine Blend (BPC-157 + TB-500) is typically dosed: BPC daily, TB-500 twice weekly for Acute soft-tissue injury (loading); BPC daily, TB-500 weekly for Chronic tendinopathy; BPC 3-4x weekly, TB-500 fortnightly for Maintenance after recovery.
BPC-157: Not FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. Wolverine Blend (BPC-157 + TB-500): Neither component is FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free